1. Oracle partners with Ci4CC to enhance oncology care through AI. 2. Collaboration focuses on EHR design and clinical trial innovation. 3. AI and data science are pivotal in advancing cancer research. 4. Integration of Oracle's technology aims for personalized medicine. 5. Partnership fosters collaboration in cancer informatics and research.
The collaboration signals growth potential in the healthcare AI sector, which can drive future revenues and strengthen ORCL’s market position, mirroring previous partnerships that resulted in successful product innovations.
This collaboration can enhance Oracle's reputation and capabilities in the healthcare AI industry, likely impacting stock performance given the rising demand for AI-driven healthcare solutions.
The strategic nature of this partnership and its potential to develop new solutions for oncology will likely take time to materialize, similar to ORCL's previous long-term engagements that evolved into significant revenue streams.
Strategic collaboration to leverage Ci4CC's national network and Oracle's technology to help advance AI in oncology, EHR interoperability, next-gen clinical trials, and personalized medicine
MIAMI BEACH, Fla., Nov. 7, 2025 /PRNewswire/ -- 24th Cancer Center Informatics Society Symposium -- Oracle Health and Life Sciences and the Cancer Center Informatics Society (Ci4CC), a nonprofit uniting cancer centers, researchers, and industry innovators, are collaborating to advance AI innovation in oncology care and research.
The collaboration aims to bring together Oracle's technology with Ci4CC's Initiatives Program and national network of NCI-Designated and Community Care Cancer Centers. The two organizations plan to collaborate to design an EHR optimized for cancer care.
"Cancer remains a leading cause of death worldwide, but AI and data science have become powerful allies in the fight," said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. "Combining Ci4CC's unparalleled expertise and network with our state-of-the-art proven AI-powered healthcare applications, we have the opportunity to accelerate discoveries that can help cure cancer."
The strategic collaboration intends to develop initiatives across oncology care and clinical research. This includes integrating clinical and genomic data for personalized medicine solutions, pioneering AI-driven approaches for clinical trial innovation and drug development, establishing robust real-world evidence frameworks, and advancing precision oncology platforms.
"This alliance with Oracle marks a significant milestone for Ci4CC and our mission to further cancer informatics," said Sorena Nadaf-Rahrov, MS, MMI, PhDc, President & CEO - Cancer Center Informatics Society. "Advancements in cancer research and clinical care are not achieved in isolation. That's why fostering such collaborative networks is fundamental to our Initiatives Program, and central to the Society's mission.
By integrating Oracle's cutting-edge and AI-enabled technology with real-world data from our national network of NCI-Designated and Community Cancer Centers, we hope to incubate and operationalize initiatives that will redefine cancer research and patient care. Turning data into knowledge, and knowledge into health continues to drive the Cancer Center Informatics Society forward."
The collaboration is part of a non-binding agreement.
For more information about Ci4CC visit: https://www.ci4cc.org/.
To learn more about Oracle's commitment to advancing health and life sciences, visit: https://www.oracle.com/life-sciences/
About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE:ORCL), please visit us at www.oracle.com.
Trademarks
Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.
View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-and-ci4cc-partner-to-accelerate-oncology-innovation-302608712.html
SOURCE Oracle